<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221119056537N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-08-10</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Comparison of the effect of Thyme  and Chlorhexidine glucosan mouthwash on oral health of ventilated patients in the intensive care unit</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effect of Thyme  and Chlorhexidine glucosan mouthwash on oral health of ventilated patients in the intensive care unit</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-09-05</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>46</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71558</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Other, Randomization description: This method is used to avoid significant imbalances in the number of participants assigned to each group. Block randomization guarantees that there is no significant imbalance between the groups at any time during the randomization and at certain points the number of participants in each group is equal. Then the list of blocks is written and numbers are assigned to them (AABB(1)- ABAB(2)-ABBA(3)-BBAA(4)- BABA(5)- BAAB(6)) then choosing random numbers between 1 to 6 (for example 1 4 5 and...) and finally defining the treatment allocation list based on the previous random numbers (...AABB-BBAA-BABA-). In this design, the randomization unit is individual, Blinding description: 1) The study participants are blind due to their low level of consciousness and being intubated.
2) The researcher will only apply chlorhexidine and thyme mouthwash by numbering them and will not know the identity of each mouthwash.
3) Statistical analysts will also analyze the data through coding.</study_design>
      <phase>3</phase>
      <hc_freetext>Intubated patients hospitalized in intensive care unite.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Before each intervention, the patient's position will be supine, and if not prohibited, the patient's head will be raised 30 degrees and turned to one side. Before using the mouthwash to prevent microaspiration, the tracheal tube cuff pressure will be measured once for both groups, and then the cuff stiffness method will be used for the next times to ensure the appropriate pressure of the cuff. Before the intervention, the entire surface of the mouth, gums and teeth will brushed with a soft toothbrush. For patients in the intervention group, five milliliters of thyme mouthwash will be administered three times a day (every eight hours) as a wet swab for five days. Intervention 2: Control group:  Before each intervention, the patient's position will be supine, and if not prohibited, the patient's head will be raised 30 degrees and turned to one side. Before using the mouthwash to prevent microaspiration, the tracheal tube cuff pressure will be measured once for both groups, and then the cuff stiffness method will be used for the next times to ensure the appropriate pressure of the cuff. Before the intervention, the entire surface of the mouth, gums and teeth will brushed with a soft toothbrush.  For patients in the intervention group, five milliliters of Chlorhexidine  mouthwash will be administered three times a day (every eight hours) as a wet swab for five days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>No - There is not a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for not sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Haniyeh Samarghandi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Univercity street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>١٣٩۴۴ ٩١٣٨٨</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>samarghandih992@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Haniyeh Samarghandi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>University street</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>١٣٩۴۴ ٩١٣٨٨</zip>
        <telephone>+98 51 3859 1511</telephone>
        <email>samarghandih992@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1) Older than 18 years old
2) The patient needs mechanical ventilation at least for 48 hours
3) The airway used for the patient is a tracheal tube.
4) Not using an  endotracheal tube before admission to the intensive care unit
5) Consent to participate in the study by the patient or guardian
6) Not having pneumonia during hospitalization in the intensive care unit
7) No history of allergy to herbal compounds
8) Not having an autoimmune disease or immune system deficiency
9) Absence of obvious  lesions in and around the mouth upon admission
Having a nasogastric tube for feeding</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>pregnancy
extubation
transfer from the intensive care unit to the ward or death of the patient</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>J39</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Other diseases of upper respiratory tract</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Before each intervention, the patient's position will be supine, and if not prohibited, the patient's head will be raised 30 degrees and turned to one side. Before using the mouthwash to prevent microaspiration, the tracheal tube cuff pressure will be measured once for both groups, and then the cuff stiffness method will be used for the next times to ensure the appropriate pressure of the cuff. Before the intervention, the entire surface of the mouth, gums and teeth will brushed with a soft toothbrush. For patients in the intervention group, five milliliters of thyme mouthwash will be administered three times a day (every eight hours) as a wet swab for five days.</i_keyword>
      <i_keyword>Control group:  Before each intervention, the patient's position will be supine, and if not prohibited, the patient's head will be raised 30 degrees and turned to one side. Before using the mouthwash to prevent microaspiration, the tracheal tube cuff pressure will be measured once for both groups, and then the cuff stiffness method will be used for the next times to ensure the appropriate pressure of the cuff. Before the intervention, the entire surface of the mouth, gums and teeth will brushed with a soft toothbrush.  For patients in the intervention group, five milliliters of Chlorhexidine  mouthwash will be administered three times a day (every eight hours) as a wet swab for five days.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Oral health score in oral health assessment questionnaire. Timepoint: Before the intervention, two and five days after using thyme and chlorhexidine mouthwash. Method of measurement: oral health assessment questionnaire.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-05-29</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences, School of Nursing and Midwifery</contact_name>
        <contact_address>University St., Doctor's Road, Faculty of Nursing and Midwife Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
